Genetic alterations in the PI3K/mTOR pathway are not uncommon in SCLC [9, 10], with typically mutually exclusive alterations in PIK3CA, PTEN, AKT2, AKT3, RICTOR, or MTOR found in 36% of patients [10]. This evidence concerns the gene PTEN and small cell lung carcinoma.